文献速递角膜与眼表疾病

聚乙二醇与儿茶素纳米复合物对小鼠模型干眼病的治疗功效

Therapeutic Efficacy of Nanocomplex of Poly(Ethylene Glycol) and Catechin for Dry Eye Disease in a Mouse Model.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

研究在干眼病小鼠模型中评估聚乙二醇(PEG)与儿茶素纳米复合物治疗干眼病的可能性。NOD.B10.H2b小鼠经气流和东莨菪碱暴露10天后,分别给予生理盐水、1%儿茶素、1% PEG及三种重量比的儿茶素/PEG纳米复合物溶液(CP1、CP5、CP10),每日5次治疗10天。结果显示PEG/儿茶素纳米复合物以PEG剂量依赖方式有效增加泪液分泌、稳定角膜上皮、增加结膜杯状细胞并改善抗炎。

要点

  • PEG/儿茶素纳米复合物以PEG剂量依赖方式增加泪液分泌、稳定角膜上皮、增加结膜杯状细胞并改善抗炎。
  • 干燥应激显著降低泪液分泌、增加角膜不规则评分、增加上皮脱落、减少结膜杯状细胞并诱导泪腺促炎因子表达。
  • 作者认为PEG可能提高儿茶素的生物利用度,PEG/儿茶素纳米复合物可通过稳定泪膜和抑制炎症用于治疗干眼病。

核心结论

  • 本研究发现PEG可能提高儿茶素的生物利用度,因此PEG/儿茶素纳米复合物可通过稳定泪膜和抑制炎症作为治疗干眼病的新生物医学材料。

研究设计与样本

  • NOD.B10.H2b小鼠暴露于气流并注射东莨菪碱10天建立干眼模型,随后分别给予生理盐水(n=11)、1%儿茶素(n=11)、1% PEG(n=11)及1%儿茶素/PEG纳米复合物溶液(儿茶素与PEG重量比1:1(CP1,n=11)、1:5(CP5,n=11)、1:10(CP10,n=11)),所有治疗每日5次、持续10天。

主要发现

  • 干燥应激显著降低泪液分泌并增加角膜不规则评分。
  • 干燥应激显著增加上皮脱落并减少结膜杯状细胞数量。
  • 干燥应激显著诱导泪腺中促炎相关因子的表达。
  • PEG/儿茶素纳米复合物以PEG剂量依赖方式有效增加泪液分泌、稳定角膜上皮、增加结膜杯状细胞并改善抗炎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We investigated the possibility of the nanocomplex of poly(ethylene glycol) (PEG) and catechin as a new biomedical material to treat dry eye disease. METHODS: NOD.B10.H2b mice were exposed to an air draft and injected with scopolamine for 10 days. Ten days later, the mice were treated with normal saline (n = 11), 1% catechin (n = 11), 1% PEG (n = 11), and 1% catechin/PEG nanocomplex solution mixture containing catechin and PEG at weight ratios of 1:1 (CP1, n = 11), 1:5 (CP5, n = 11), and 1:10 (CP10, n = 11). All treatments were administered five times a day for 10 days. We estimated the effect of PEG/catechin nanocomplexes on inflammation, tear production, epithelium stabilization, and goblet cell density. RESULTS: Desiccation stress significantly decreased tear production and increased the corneal irregularity score. Furthermore, desiccation stress markedly increased the detached epithelium and decreased the numbers of conjunctival goblet cells. In addition, the expression of proinflammatory-related factors was markedly induced by desiccation stress in the lacrimal glands. However, the PEG/catechin nanocomplex effectively induced an increase in tear production, stabilization of the corneal epithelium, and an increase in conjunctival goblet cells and anti-inflammatory improvements in a PEG dose-dependent manner. CONCLUSIONS: In this study, we found that PEG may increase bioavailability of catechin. Therefore, the PEG/catechin nanocomplex can be used as a new biomedical material to treat dry eye disease through stabilization of the tear film and inhibition of inflammation.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Lee H, Shim W, Kim CE, et al. Therapeutic Efficacy of Nanocomplex of Poly(Ethylene Glycol) and Catechin for Dry Eye Disease in a Mouse Model. Invest Ophthalmol Vis Sci. 2017. PMID: 28319642. doi:10.1167/iovs.16-20843

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。